AbbVie: BofA Global Research raises price objective to $305 from $289
ABBV•BofA Global Research raised its price objective for AbbVie to $305 from $289.
Related News
Global markets: Oil eases, bringing some respite to stocks and battered bonds
SPY•
Alignment Healthcare cut to neutral from buy at BofA Global Research; price objective cut to $9 from $25
ALHC•
Nasdaq pauses trading in PCSA for volatility at 10:28 a.m.
PCSA•
Merck & Co Inc: BofA Global Research cuts price objective to $163 from $166
MRK•
TIM updates financial events calendar for 2026
TIMB•